EcoDrugPlus

Histamine Receptor H3

Ensembl ID : ENSLACG00000006816
Gene Symbol: HRH3
4 Cross references
118 Possible Orthologues:

Histone Deacetylase 1

Ensembl ID : ENSLACG00000013376
Gene Symbol: HDAC1
2 Cross references
305 Possible Orthologues:

Histone Deacetylase 10

Ensembl ID : ENSLACG00000016386
Gene Symbol: HDAC10
3 Cross references
181 Possible Orthologues:

Histone Deacetylase 11

Ensembl ID : ENSLACG00000009362
Gene Symbol: HDAC11
3 Cross references
202 Possible Orthologues:

Histone Deacetylase 4

Ensembl ID : ENSLACG00000007465
Gene Symbol: HDAC4
3 Cross references
265 Possible Orthologues:

Histone Deacetylase 5

Ensembl ID : ENSLACG00000016167
Gene Symbol: HDAC5
3 Cross references
196 Possible Orthologues:

Histone Deacetylase 6

Ensembl ID : ENSLACG00000007008
Gene Symbol: HDAC6
3 Cross references
184 Possible Orthologues:

Histone Deacetylase 7

Ensembl ID : ENSLACG00000019112
Gene Symbol: HDAC7
4 Cross references
260 Possible Orthologues:

Histone Deacetylase 8

Ensembl ID : ENSLACG00000011351
Gene Symbol: HDAC8
4 Cross references
205 Possible Orthologues:

Histone Deacetylase 9

Ensembl ID : ENSLACG00000015595
Gene Symbol: HDAC9
4 Cross references
234 Possible Orthologues:

Hydroxysteroid 11-Beta Dehydrogenase 1

Ensembl ID : ENSLACG00000018614
Gene Symbol: HSD11B1
4 Cross references
274 Possible Orthologues:

Hyperpolarization Activated Cyclic Nucleotide Gated Potassium Channel 4

Ensembl ID : ENSLACG00000001630
Gene Symbol: HCN4
4 Cross references
287 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).